Prostate Cancer - Results from #320

Using Prostate Imaging-Reporting and Data System (PI-RADS) Scores to Select an Optimal Prostate Biopsy Method: A Secondary Analysis of the Trio Study - Beyond the Abstract July 7, 2021

Effectiveness and Distribution of Testosterone Levels within First Year of Androgen Deprivation Therapy in a Real-World Setting: Results from the Non-Interventional German Cohort LEAN Study - Beyond the Abstract June 28, 2021

What’s Important for Improving Biopsy Acquisition, Is Lesion Selection a Key? A Specialized, Web-Based Naing Tool for Target Lesion Selection - Beyond the Abstract June 23, 2021

Attenuation of SRC Kinase Activity Augments PARP Inhibitor-Mediated Synthetic Lethality in BRCA2-Altered Prostate Tumors - Beyond the Abstract June 18, 2021

Overall Survival of Men with Metachronous Metastatic Hormone-Sensitive Prostate Cancer Treated with Enzalutamide and Androgen Deprivation Therapy - Beyond the Abstract June 1, 2021

PHI Density Prospectively Improves Prostate Cancer Detection - Beyond the Abstract May 25, 2021

Phase 3 Multicenter Randomized Trial of PSMA PET/CT Prior to Definitive Radiation Therapy for Unfavorable Intermediate-Risk or High-Risk Prostate Cancer [PSMA dRT]: Study Protocol - Beyond the Abstract May 21, 2021

MRI Predicts Prostatic Urethral Involvement in Men Undergoing Radical Prostatectomy: Implications for Cryo-Ablation of Localized Prostate Cancer - Beyond the Abstract May 17, 2021

Race Reporting and Diversity in US Food and Drug Administration (FDA) Registration Trials for Prostate Cancer; 2006-2020 - Beyond the Abstract May 13, 2021

Genomic Analysis of Circulating Tumor DNA in 3,334 Patients with Advanced Prostate Cancer Identifies Targetable BRCA Alterations and AR Resistance Mechanisms - Beyond the Abstract May 13, 2021

Pros-IT CNR: An Italian Prostate Cancer Monitoring Project - Beyond the Abstract May 12, 2021

Evaluation of [68Ga]Ga-PSMA PET/CT Images Acquired with a Reduced Scan Time Duration in Prostate Cancer Patients Using the Digital Biograph Vision - Beyond the Abstract May 11, 2021

Defining Oligometastatic Hormone Sensitive Prostate Cancer and Clinically Significant Outcomes: Implications on Clinical Trials? - Beyond the Abstract May 6, 2021

Molecular Medicine Tumor Board: Whole-Genome Sequencing to Inform on Personalized Medicine for a Man with Advanced Prostate Cancer - Beyond the Abstract May 3, 2021

Tissue Expression of Androgen Receptor Splice Variant 7 at Radical Prostatectomy Predicts Risk of Progression in Untreated Nonmetastatic Prostate Cancer - Beyond the Abstract April 29, 2021

Patterns of Disease Detection Using [18F]DCFPyL PET/CT Imaging in Patients with Detectable PSA Post Prostatectomy Being Considered for Salvage Radiotherapy: A Prospective Trial - Beyond the Abstract April 27, 2021

Preliminary Development of a Mindfulness-Based Group Therapy to Expand Couples' Sexual Intimacy After Prostate Cancer: A Mixed Methods Approach - Beyond the Abstract April 26, 2021

A 38-Gene Model Comprised of Key TET2-Associated Genes Shows Additive Utility to High-Risk Prostate Cancer Cases in the Prognostication of Biochemical Recurrence - Beyond the Abstract April 21, 2021

Stereotactic Body Radiotherapy and High-Dose Rate Brachytherapy Boost in Combination with Intensity Modulated Radiotherapy for Localized Prostate Cancer: A Single-Institution Propensity Score Matched Analysis - Beyond the Abstract April 15, 2021

Refining Immuno-Oncology Approaches in Metastatic Prostate Cancer: Transcending Current Limitations – Beyond the Abstract March 31, 2021

Page 17 of 58